Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

December 01, 2019; Volume 47,Issue 12

Minireview

  • You have access
    Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges
    Simone Schadt, Simon Hauri, Filipe Lopes, Martin R. Edelmann, Roland F. Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B. Roth, Franz Schuler, Wolfgang F. Richter and Christoph Funk
    Drug Metabolism and Disposition December 2019, 47 (12) 1443-1456; DOI: https://doi.org/10.1124/dmd.119.088997

Articles

  • You have access
    In Vitro–In Vivo Inaccuracy: The CYP3A4 Anomaly
    Christine M. Bowman and Leslie Z. Benet
    Drug Metabolism and Disposition December 2019, 47 (12) 1368-1371; DOI: https://doi.org/10.1124/dmd.119.088427
  • You have access
    Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms
    Hyunyoung Lee, Jae-Kyung Heo, Ga-Hyun Lee, So-Young Park, Su-Nyeong Jang, Hyun-Ji Kim, Mi Jeong Kwon, Im-Sook Song and Kwang-Hyeon Liu
    Drug Metabolism and Disposition December 2019, 47 (12) 1372-1379; DOI: https://doi.org/10.1124/dmd.119.087965
  • You have access
    An Accurate In Vitro Prediction of Human VDss Based on the Øie–Tozer Equation and Primary Physicochemical Descriptors. 3. Analysis and Assessment of Predictivity on a Large Dataset
    Giuliano Berellini and Franco Lombardo
    Drug Metabolism and Disposition December 2019, 47 (12) 1380-1387; DOI: https://doi.org/10.1124/dmd.119.088914
  • You have access
    Role of l- and d-Menthol in the Glucuronidation and Detoxification of the Major Lung Carcinogen, NNAL
    Shannon Kozlovich, Gang Chen, Christy J.W. Watson, William J. Blot and Philip Lazarus
    Drug Metabolism and Disposition December 2019, 47 (12) 1388-1396; DOI: https://doi.org/10.1124/dmd.119.088351
  • You have access
    Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation
    Hong-Jaan Wang and Leslie Z. Benet
    Drug Metabolism and Disposition December 2019, 47 (12) 1397-1402; DOI: https://doi.org/10.1124/dmd.119.088872
  • You have access
    Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy
    Minjee Kim, Janice K. Laramy, Gautham Gampa, Karen E. Parrish, Richard Brundage, Jann N. Sarkaria and William F. Elmquist
    Drug Metabolism and Disposition December 2019, 47 (12) 1403-1414; DOI: https://doi.org/10.1124/dmd.119.088716
  • Open Access
    Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations
    Ritah F. Mutagonda, Omary M.S. Minzi, Siriel N. Massawe, Muhammad Asghar, Anna Färnert, Appolinary A.R. Kamuhabwa and Eleni Aklillu
    Drug Metabolism and Disposition December 2019, 47 (12) 1415-1424; DOI: https://doi.org/10.1124/dmd.119.088062
  • You have access
    CYP2D1 Gene Knockout Reduces the Metabolism and Efficacy of Venlafaxine in Rats
    Hongqiu Zhou, Li Yang, Changsuo Wang, Zhiqiang Li, Zhen Ouyang, Mangting Shan, Jun Gu and Yuan Wei
    Drug Metabolism and Disposition December 2019, 47 (12) 1425-1432; DOI: https://doi.org/10.1124/dmd.119.088526
  • You have access
    Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo
    Congrong Niu, Yujin Wang, Xiaofeng Zhao, Sam Tep, Eisuke Murakami, Raju Subramanian, Bill Smith and Yurong Lai
    Drug Metabolism and Disposition December 2019, 47 (12) 1433-1442; DOI: https://doi.org/10.1124/dmd.119.088922
  • Open Access
    An Innovative Approach to Characterize Clinical ADME and Pharmacokinetics of the Inhaled Drug Nemiralisib Using an Intravenous Microtracer Combined with an Inhaled Dose and an Oral Radiolabel Dose in Healthy Male Subjects
    Andrew W. Harrell, Robert Wilson, Yau Lun Man, Kylie Riddell, Emily Jarvis, Graeme Young, Robert Chambers, Lee Crossman, Alex Georgiou, Adrian Pereira, David Kenworthy, Claire Beaumont, Miriam Marotti, Denisa Wilkes, Edith M. Hessel and William A. Fahy
    Drug Metabolism and Disposition December 2019, 47 (12) 1457-1468; DOI: https://doi.org/10.1124/dmd.119.088344
  • You have access
    Toxicokinetic Interaction between Hepatic Disposition and Pulmonary Bioactivation of Inhaled Naphthalene Studied Using Cyp2abfgs-Null and CYP2A13/2F1-Humanized Mice with Deficient Hepatic Cytochrome P450 Activity
    Nataliia Kovalchuk, Qing-Yu Zhang, Jacklyn Kelty, Laura Van Winkle and Xinxin Ding
    Drug Metabolism and Disposition December 2019, 47 (12) 1469-1478; DOI: https://doi.org/10.1124/dmd.119.088930
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 47 (12)
Drug Metabolism and Disposition
Vol. 47, Issue 12
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics